PYC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PYC Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 1.98 AUD -7.48% Market Closed

Market Cap: AU$1.9B

	PYC Therapeutics Ltd ASX:PYC	AU
A	Allstate Corp XMUN:ALS	US
	IntegraFin Holdings plc F:84N	UK

Profitability Summary

PYC Therapeutics Ltd's profitability score is 20/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-108%

Negative 3Y Average Operating Margin

-156%

Operating Margin is Increasing

-146% > -108%

Negative Net Margin

-109%

Negative 3Y Average Net Margin

-157%

Net Margin is Increasing

-143% > -109%

Negative Free Cash Flow Margin

-114%

Negative 3Y Average Free Cash Flow Margin

-172%

Free Cash Flow Margin is Increasing

-157% > -114%

Negative ROE

-10%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-277%

ROIC is Increasing

-156% > -32%

View All

Hide

Collapse

20 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.